Three trials were published comparing reboxetine against other antidepressants in which reboxetine was just as good, and they were published, but three times as many patients' worth of data was collected which showed that reboxetine was worse than those other treatments, and those trials were not published. I felt misled.
Tres ensayos fueron publicados comparando reboxetine con otros antidepresivos, en los que reboxetine era igual de bueno, y fueron publicados, pero se reunió información de el triple de pacientes que mostraron que reboxetine era peor que los otros tratamientos y esos ensayos no se publicaron. Me sentí engañado.